PRDS - Pardes Biosciences - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

PRDS is currently covered by 2 analysts with an average price target of $3.9. This is a potential upside of $1.74 (80.56%) from yesterday's end of day stock price of $2.16.

Pardes Biosciences's activity chart (see below) currently has 2 price targets and 5 ratings on display. The stock rating distribution of PRDS is 33.33% BUY and 66.67% HOLD.

Stock Analyst Price Targets - Review

Highest price target for PRDS is $2, Lowest price target is $1, average price target is $3.9.

Most recent stock forecast was given by ROY BUCHANAN from JMP on 18-Jul-2023. First documented stock forecast 18-Jan-2022.

Best performing analysts who are covering PRDS - Pardes Biosciences:

Dennis Ding Roy Buchanan

Currently out of the existing stock ratings of PRDS, 1 are a BUY (33.33%), 2 are a HOLD (66.67%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

5

9 months ago

0/1 (0%)

$3.65 (270.37%)

Hold

1.25

$-0.91 (-42.13%)

25

1 years 15 days ago

0/3 (0%)

$-0.18 (-12.59%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PRDS (Pardes Biosciences) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on PRDS (Pardes Biosciences) with a proven track record?

DENNIS DING

Which analyst has the current lower performing score on PRDS (Pardes Biosciences) with a proven track record?

ROY BUCHANAN

Which analyst has the most public recommendations on PRDS (Pardes Biosciences)?

Dennis Ding works at JEFFERIES and has 3 price targets and 2 ratings on PRDS

Which analyst is the currently most bullish on PRDS (Pardes Biosciences)?

Roy Buchanan with highest potential upside - $0

Which analyst is the currently most reserved on PRDS (Pardes Biosciences)?

Dennis Ding with lowest potential downside - -$0.91

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?